Trials / Recruiting
RecruitingNCT07292779
A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds
A Prospective, Clinical Investigation to Evaluate the Performance and Safety of DMFI150 for the Treatment of Nasolabial Folds
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Samyang Biopharmaceuticals Corporation · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective clinical investigation designed to evaluate the performance and safety of DMFI150 for the treatment of nasolabial folds. 30 adult participants will receive a single treatment with the investigational device. The study will assess wrinkle severity using validated aesthetic evaluation scales, as well as overall safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DMFI150 | Injection of DMFI150 for nasolabial folds. |
Timeline
- Start date
- 2025-11-24
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2025-12-18
- Last updated
- 2026-03-05
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT07292779. Inclusion in this directory is not an endorsement.